Tenet Healthcare Raises FY2026 Adj EPS Guidance from $16.19-$18.47 to $16.38-$18.68 vs $17.21 Est; Affirms FY2026 Sales Guidance of $21.500B-$22.300B vs $22.017B Est

Benzinga Newsdesk www.benzinga.com Positive 79.5%

Neg 0% Neu 0% Pos 79.5%

Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $16.19-$18.47 to $16.38-$18.68 vs $17.21 analyst estimate. Affirms FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.500 billion-$22.300 billion vs $22.017 billion estimate.